AJIC: American Journal of Infection Control
Volume 34, Issue 5 , Page E113, June 2006

Reducing the Number One Health Care Acquired Infection Utilizing a Silver-Impregnated Foley with Bacteriostatic Tubing/Bag System

  • A. Hutchins, BSN

      Affiliations

    • Quality Regulatory and Compliance, Jackson Hospital & Clinic, Montgomery, AL, USA

Publication Number 14-135

BACKGROUND/OBJECTIVES: Catheter-associated urinary tract infections (CAUTI) historically are the number one healthcare-acquired infection (HAI). Zero tolerance of HAI's is a National APIC initiative by 2012. Use of antiseptic urinary catheters has demonstrated reductions in CAUTI's. We compared rates of CAUTI's with the standard Foley/drainage system (baseline) and the silver-coated Foley catheter with antiseptic-impregnated drainage system (intervention).

METHODS: A baseline CAUTI rate was established over a 3-month time period using standard latex catheters and drainage systems (A non-Bard product). Retrospective medical review was conducted of all qualifying positive urine cultures during December 1, 2003 through February 28, 2004. Definitions used were those presented at APIC 2004 in the abstract by Ritter, Watson, et al, “Redefining Catheter Associated UTI (CAUTI): Are New Definitions Necessary?” The Bardex®I.C. Complete Care™ System (Bard Medical, Covington, Georgia) with the antiseptic Foley catheter and antiseptic drainage system was the product used for the intervention time period of December 1, 2004 through February 28, 2005. The same qualifying criterion was used for the retrospective review of medical records for the intervention time period.

RESULTS: A total of 43 medical records qualified for review (standard Foley catheter). From these, 21 CAUTI's were identified among 14, 375 patient days. During the intervention period, utilizing the antiseptic catheter/drain bag system, 35 medical records qualified for review, from which 11 CAUTI's were identified among 14,035 patient days. The CAUTI rate was reduced from 1.5 cases/1,000 patient days in the standard catheter period to .8 cases per 1,000 patent days in the antiseptic catheter/drainage system period. This represents a 46.6% rate reduction. (RR: 0.536; CI upper limit per 1000 = 1.10, lower limit per 1000 = −1.45; p-value Fisher Exact = 0.089).

CONCLUSIONS: The implementation of the Bardex ®I.C. Complete Care™ system was instrumental in reducing of HAI CAUTI's with in our hospital, preventing 10 CAUTI's during the evaluation time period. A projected annualized reduction of 40 CAUTI's would occur and a cost avoidance of ∼ $52,685.04.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0196-6553(06)00609-2

doi:10.1016/j.ajic.2006.05.086

AJIC: American Journal of Infection Control
Volume 34, Issue 5 , Page E113, June 2006